Silence Therapeutics plc (SLNCF)
Market Closed
31 Aug, 20:00
OTC PINK OTC PINK Primary $
4. 00
0
0%
$
623.5M Market Cap
- P/E Ratio
- Div Yield
500 Volume
0 Eps
$ 4
Previous Close 
Want to track SLNCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Silence Therapeutics plc (SLNCF) Statistics
Valuation metrics
Market Cap 623.5M
Enterprise value 561.94M
Trailing P/E (ttm) -3.52
Forward P/E -
PEG ratio -0.26
Price/Sales (ttm) 1,031.89
Price/Book (mrq) 5.49
Enterprise Value/Revenue 914.77
Enterprise Value/EBITDA -9.32
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 500
Average volume (90 days) 2.67K
Price summary
52-Week low 1.06
52-Week high 5.99
Beta -
50-Day moving average 1.81
200-Day moving average 1.84
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 30 Apr 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -97.59%
Operating margin -108.8%
Operational effectiveness
Return on assets -0.56%
Return on equity -1.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 7.42%
Book value per share (mrq) 2.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
